Human cadaveric donor cornea derived extra cellular matrix microparticles for minimally invasive healing/regeneration of corneal wounds

Abstract

Biological materials derived from extracellular matrix (ECM) proteins have garnered interest as their composition is very similar to that of native tissue. Herein, we report the use of human cornea derived decellularized ECM (dECM) microparticles dispersed in human fibrin sealant as an accessible therapeutic alternative for corneal anterior stromal reconstruction. dECM microparticles had good parti-cle size distribution (≤10 μm) and retained the majority of corneal ECM components found in native tis-sue. Fibrin–dECM hydrogels exhibited compressive modulus of 70.83 ± 9.17 kPa matching that of native tissue, maximum burst pressure of 34.3 ± 3.7 kPa, and demonstrated a short crosslinking time of ~17 min. The fibrin–dECM hydrogels were found to be biodegradable, cytocompatible, non‐mutagenic, non‐sen-sitive, non‐irritant, and supported the growth and maintained the phenotype of encapsulated human corneal stem cells (hCSCs) in vitro. In a rabbit model of anterior lamellar keratectomy, fibrin–dECM bio-adhesives promoted corneal re‐epithelialization within 14 days, induced stromal tissue repair, and dis-played integration with corneal tissues in vivo. Overall, our results suggest that the incorporation of cornea tissue‐derived ECM microparticles in fibrin hydrogels is non‐toxic, safe, and shows tremendous promise as a minimally invasive therapeutic approach for the treatment of superficial corneal epithelial wounds and anterior stromal injuries.